Top Medical News Today

Aflibercept May Target Galectin-1, a Novel Angiogenic Factor Associated with Proliferative Diabetic Retinopathy
Aflibercept exerts anti-angiogenic effects against galectin-1, a galactoside-binding lectin protein and novel angiogenic factor associated with proliferative diabetic retinopathy.
After 12 or 24 monthly injections, ranibizumab, one of three currently available vascular endothelial growth factor antibodies, caused regression of diabetic retinopathy (DR) in at least 75% of patients who had diabetic macular edema and whose DR severity put them at the highest risk of progression to proliferative DR.
Andrew Hartwick, PhD, Associate Professor at The College of Optometry at The Ohio State University discussed his research surrounding traumatic brain injury (TBI) patients who experience increased light sensitivity, or photophobia.
It may seem like elite athletes have a leg up on non-sports players when it comes to eye control, but research out of the University of Bradford in the United Kingdom says that’s not exactly the case.
Patients with the hereditary degenerative eye disease retinitis pigmentosa (RP) may delay their loss of daytime vision by taking a traditional Chinese plant remedy Lycium barbarum also known as goji berry or wolfberry
A team of surgeons has demonstrated a surgical model using cadavers for total human eye allotransplantation.
"We hope there are strategies for regeneration of the optic nerve and making synaptic connections to the higher order brain structure, because those are the key issues."
Patients with epilepsy will soon have another option to control seizures with the approval of a new formulation of perampanel (Fycompa), developed by Eisai Inc.
Sometimes things we enjoy cause harm, and our career can be one of those things....how do you make sense of that?

Most Popular


$vacMongoViewPlus$ $vAR$